Skip to Content

WPI 3355 (Nateglinide 120 mg)

Pill with imprint WPI 3355 is Pink, Capsule-shape and has been identified as Nateglinide 120 mg. It is supplied by Watson Laboratories Inc..

Nateglinide is used in the treatment of diabetes, type 2 and belongs to the drug class meglitinides. Risk cannot be ruled out during pregnancy. Nateglinide 120 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 3355

Nateglinide

Imprint:
WPI 3355
Strength:
120 mg
Color:
Pink
Size:
17.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Meglitinides
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Laboratories Inc.
National Drug Code (NDC):
00591-3355
Inactive Ingredients:

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide